ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Price & Overview
NASDAQ:AVR • US03675P1021
Current stock price
The current stock price of AVR is 5.5 USD. Today AVR is up by 3.38%. In the past month the price decreased by -13.11%. In the past year, price increased by 70.81%.
AVR Key Statistics
- Market Cap
- 534.765M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.55
- Dividend Yield
- N/A
AVR Stock Performance
AVR Stock Chart
AVR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AVR. When comparing the yearly performance of all stocks, AVR is one of the better performing stocks in the market, outperforming 87.05% of all stocks.
AVR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVR. AVR may be in some trouble as it scores bad on both profitability and health.
AVR Earnings
On February 26, 2026 AVR reported an EPS of -0.74 and a revenue of 310.00K. The company missed EPS expectations (-24.18% surprise) and beat revenue expectations (53.47% surprise).
AVR Forecast & Estimates
8 analysts have analysed AVR and the average price target is 15.5 USD. This implies a price increase of 181.89% is expected in the next year compared to the current price of 5.5.
For the next year, analysts expect an EPS growth of 52.47% and a revenue growth 251.67% for AVR
AVR Groups
Sector & Classification
AVR Financial Highlights
Over the last trailing twelve months AVR reported a non-GAAP Earnings per Share(EPS) of -2.55. The EPS decreased by -20.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -409.38% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AVR Ownership
AVR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVR
Company Profile
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Company Info
IPO: 2024-12-13
ANTERIS TECHNOLOGIES GLOBAL
860 Blue Gentian Road, Suite 340
Eagan MINNESOTA US
Employees: 174
Phone: 16514930606
ANTERIS TECHNOLOGIES GLOBAL / AVR FAQ
What does ANTERIS TECHNOLOGIES GLOBAL do?
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Can you provide the latest stock price for ANTERIS TECHNOLOGIES GLOBAL?
The current stock price of AVR is 5.5 USD. The price increased by 3.38% in the last trading session.
Does ANTERIS TECHNOLOGIES GLOBAL pay dividends?
AVR does not pay a dividend.
How is the ChartMill rating for ANTERIS TECHNOLOGIES GLOBAL?
AVR has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for ANTERIS TECHNOLOGIES GLOBAL?
ANTERIS TECHNOLOGIES GLOBAL (AVR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the PE ratio for AVR stock?
ANTERIS TECHNOLOGIES GLOBAL (AVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.55).
What is ANTERIS TECHNOLOGIES GLOBAL worth?
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a market capitalization of 534.76M USD. This makes AVR a Small Cap stock.